HempFusion Launches Probulin Probiotics in Ireland’s Top Retailer
June 10 2021 - 07:05AM
Business Wire
HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO)
(“HempFusion” or the “Company”), a leading health and wellness
Company offering premium probiotic supplements and products
containing CBD, is pleased to announce the launch of key products
through its wholly owned subsidiary, Probulin Probiotics, LLC
(“Probulin”), in Boots Ireland, the country’s leading pharmacy-led
health and beauty retailer.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210610005311/en/
Probulin Probiotic EU Lineup (Photo:
Business Wire)
HempFusion is pleased to be offering its new EU compliant
Probulin products for the Boots Ireland launch, establishing a
foundation for further opportunities and expansion in retailers
across Ireland, the United Kingdom and Europe.
Boots Ireland is part of the Retail Pharmacy International
Division of one of the world’s largest purchasers of prescription
drugs and many other health and well-being products, with one of
the largest retail footprints in the world.
“In January, we signed the initial distribution deal for Ireland
and we’re pleased that Boots, the largest pharmacy-led health and
beauty retailer in Ireland, is now stocking our products in nearly
50% of stores across the country,” commented Jon Visser, the
Company’s Chief Revenue Officer. “With many more retailers in
Ireland expected to follow suit, our immediate expansion plan
includes additional retail outlets throughout the UK and Europe,”
continued Visser.
Established in 1849, the Boots brand holds a place in the heart
of the communities it serves. Committed to providing exceptional
customer and patient care, Boots was recently recognized as the
most reputable pharmacy and retailer in Ireland (*2020 RepTrak
study).
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retail locations across all 50 states of the United States and
select international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 48 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result,”
“are expected to,” “expects,” “will continue,” “is anticipated,”
“anticipates,” “believes,” “estimated,” “intends,” “plans,”
“forecast,” “projection,” “strategy,” “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to
further opportunities and expansion of the Company’s products in
retailers across Ireland, the United Kingdom and Europe and the
Company’s other plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward-Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021, and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210610005311/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Feb 2024 to Mar 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Mar 2023 to Mar 2024